secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001104659-25-114919
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dogwood Therapeutics completes business combination with Sealbond; approves equity plan adding 2.78M shares
--------------------------------------------------------------------------------

- Stockholders approved the potential issuance of common stock upon conversion of Series A, A-1, and A-2 preferred stock.
- Business combination with Sealbond Limited (per Share Exchange Agreement dated Oct 7, 2024) is now complete.
- Second Amended and Restated Equity Incentive Plan approved, increasing reserved shares from 191,122 to 2,972,787.
- Special meeting quorum: 820,239 shares (35.76% of voting power) as of Oct 14, 2025 record date.
- All five proposals passed with >772K votes for, including adjournment and plan approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000110465925114919/0001104659-25-114919-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000110465925114919/dwtx-20251121x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-114919

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer